Immuneering Corp. (IMRX)
4.07
+0.04
(+0.99%)
USD |
NASDAQ |
Oct 02, 16:00
4.07
0.00 (0.00%)
After-Hours: 20:00
Immuneering EPS Diluted (Quarterly) : -0.2669 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2669 |
| March 31, 2026 | -0.2082 |
| December 31, 2025 | -0.1793 |
| September 30, 2025 | -0.3772 |
| June 30, 2025 | -0.4011 |
| March 31, 2025 | -0.4235 |
| December 31, 2024 | -0.5814 |
| September 30, 2024 | -0.4892 |
| June 30, 2024 | -0.4748 |
| March 31, 2024 | -0.4872 |
| December 31, 2023 | -0.5153 |
| September 30, 2023 | -0.4304 |
| June 30, 2023 | -0.4255 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.5145 |
| December 31, 2022 | -0.5016 |
| September 30, 2022 | -0.4866 |
| June 30, 2022 | -0.4369 |
| March 31, 2022 | -0.4888 |
| December 31, 2021 | -0.4097 |
| September 30, 2021 | -0.329 |
| June 30, 2021 | -0.308 |
| March 31, 2021 | -0.2442 |
| December 31, 2020 | -0.2287 |
| September 30, 2020 | -0.1696 |
| June 30, 2020 | -0.1413 |
| March 31, 2020 | -0.1254 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.27M |
| Total Expenses (Quarterly) | 17.27M |
| Enterprise Value | 117.05M |
| Earnings Yield | -25.35% |
| Normalized Earnings Yield | -25.35 |